Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279479 Method for the treatment of heart failure
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279475 Cytokine inhibitors, useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease; for example, 1-(2-methoxy-5-trifluoromethyl-phenyl)-3-{4-[6-methyl-2-(2-morpholin-4-yl-ethyl)-pyrimidin-4-yloxy]-naphthalen-1-yl}-urea
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279473 Administered singly or in combination with a second antineoplastic agent; cyclin-dependent kinase inhibitors, antiproliferative agents; coupling and cyclization of a 1-aminopyridazinium salt with a 2-alkylthio-4-alkynyl pyrimidine compound
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279471 Butane-1,4-diones 1-substituted by a phenyltriazonylpiperidinyl- or benzo-1,3-diazepinonylpiperidinyl- group, e.g., (1) 1-(1,4'-bipiperidinyl-1'-yl)-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5,-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butane-1,4-dione; treating headaches, diabetes
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279469 Diaminotriazoles useful as inhibitors of protein kinases
10/09/2007US7279468 Integrin ligands
10/09/2007US7279467 Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors
10/09/2007US7279466 Anticarcinogenic agents
10/09/2007US7279465 Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases
10/09/2007US7279463 A gene therapy using a single strand oligonucleotide to form a triple stranded nucleic acid with a target double stranded nucleic acid, hybridization to form a mutant
10/09/2007US7279458 Glycopeptide group is covalently linked to a pyridinium moiety of a cephalosporin group; reacting a glycopeptide containing (c6.c6.c6.c6.c6.c10n2.c13n2o.c13n2o ring) with a cephalosporin or salt in presence of a diacid
10/09/2007US7279331 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/09/2007US7279290 ATM kinase compositions and methods
10/09/2007US7279186 Methods of administering anti-inflammatory cyclooxygenase-2 selective inhibitors
10/09/2007US7279185 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
10/09/2007US7279183 Particularly magnesium sulfate, magnesium oxide, magnesium phosphate, or magnesium chloride
10/09/2007US7279180 Combine solutions of each vitamin, i.e, K, D's, E and A, in water or an inert oil and emulsify using a protective colloid; drying; fineness; discoloration inhibition; homogeneity; oxidation resistance
10/09/2007US7279179 Liposome-entrapped topoisomerase inhibitors
10/09/2007US7279175 Reduce restenosis coating on medical device
10/09/2007US7279160 Combinations of DR5 antibodies and other therapeutic agents
10/09/2007US7279158 Methods for the treatment of inflammatory joint disease
10/09/2007US7279146 Crystal growth devices and systems, and methods for using same
10/09/2007US7278843 Methods for fine powder formation
10/09/2007CA2529400C Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
10/09/2007CA2455012C Enteral compositions for the prevention and/or treatment of sepsis
10/09/2007CA2294579C Liposome-entrapped polynucleotide composition and method
10/09/2007CA2253393C Dispersible macromolecule compositions and methods for their preparation and use
10/09/2007CA2252084C Cytoprotective compounds
10/09/2007CA2232855C Pharmaceutical formulation
10/09/2007CA2204527C 2,2-dichloralkane-carboxylic acids, processes for their production and pharmaceutical agents containing these
10/09/2007CA2197062C Drug delivery composition containing chitosan or derivative thereof having a defined z. potential
10/09/2007CA2195428C Water-soluble esters of camptothecin compounds
10/09/2007CA2161857C Oxazolidinone derivatives as adhesion receptor antagonists
10/09/2007CA2145928C N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide, and a process for its preparation
10/09/2007CA2099503C Synthetic alpha-l-iduronidase and genetic sequences encoding same
10/07/2007CA2582394A1 Use of an antiatherothrombotic compound to produce medications for treating vascular disorders
10/06/2007WO2008125901A2 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
10/06/2007CA2639585A1 2-methylene-1.alpha., 25-dihydroxy-18, 19, 21-trinorvitamin d3 and uses thereof
10/05/2007CA2646021A1 O-glycans in the treatment of inflammatory bowel disease and cancers
10/04/2007WO2007112457A2 Aprepitant polymorph mixtures
10/04/2007WO2007112436A2 Use of polymeric materials with other substances for improved performance
10/04/2007WO2007112433A2 Compositions for promoting hair growth
10/04/2007WO2007112402A1 Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
10/04/2007WO2007112399A2 Tetrahydro-pyrazolo[3,4-c]pyridine cannabinoid modulators
10/04/2007WO2007112367A2 Potassium channel modulators and platelet procoagulant activity
10/04/2007WO2007112366A2 Animal product enrichment using resveratrol
10/04/2007WO2007112348A2 Prodrug composition
10/04/2007WO2007112347A1 Dipeptidyl peptidase inhibitors
10/04/2007WO2007112330A2 Compositions and methods for detection, prognosis and treatment of colon cancer
10/04/2007WO2007112322A2 Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
10/04/2007WO2007112280A1 Methods and compositions for making and using polymorphs of cinacalcet
10/04/2007WO2007112274A2 Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
10/04/2007WO2007112272A2 Formulations of low dose diclofenac and beta-cyclodextrin
10/04/2007WO2007112250A2 Dental appliance cleanser
10/04/2007WO2007112173A2 Method for promoting composite tissue regeneration and uses thereof
10/04/2007WO2007112098A2 Uses of diphenyl/diphenylamine carboxylic acids
10/04/2007WO2007112093A2 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
10/04/2007WO2007112091A2 Stable aqueous suspension concentrate for delivery of uv-labile water-insoluble biocides
10/04/2007WO2007112065A2 Methods for treating cognitive and other disorders
10/04/2007WO2007112043A2 Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
10/04/2007WO2007112036A2 Modified macrophage migration inhibitory factor inhibitors
10/04/2007WO2007112015A2 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
10/04/2007WO2007112014A2 New therapeutic combinations for the treatment of depression
10/04/2007WO2007112000A2 Treatment of pain
10/04/2007WO2007111994A2 Compounds and methods for treatment of disorders associated with er stress
10/04/2007WO2007111992A2 Methods and compositions for treating hypercholesterolemia and atherosclerosis
10/04/2007WO2007111982A2 Methods for treating cognitive and other disorders
10/04/2007WO2007111958A2 Method and compositions for potentiating pharmaceuticals with amino acid based medical foods
10/04/2007WO2007111954A2 Purine compounds and methods of use thereof
10/04/2007WO2007111948A2 Inhibitors of protein prenyltransferases
10/04/2007WO2007111945A2 Method for management of diarrhea
10/04/2007WO2007111933A2 Pharmaceutical compositions comprising a hypoglycemic agent and methods of using same
10/04/2007WO2007111925A2 Zotarolimus-containing drug delivery systems for implantation into a body lumen of a subject
10/04/2007WO2007111921A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
10/04/2007WO2007111880A2 Intranasal administration of ketamine to treat depression
10/04/2007WO2007111864A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
10/04/2007WO2007111806A2 Cyclopentane heptanoic acid compounds for reducing body fat
10/04/2007WO2007111720A2 Formulation of insoluble small molecule therapeutics in lipid-based carriers
10/04/2007WO2007111528A1 Agent exhibiting a neurotropic, neuromodulator, cerebrovascular and anti- stroke activity
10/04/2007WO2007111514A1 Contrast agents for magnetic resonance imaging and spectroscopy consisting of a cyclic oligoamid core of 3 to 4 identical monomer units with 3 to 4 paramagnetic chelate side chains
10/04/2007WO2007111371A1 Agent for amelioration of hyperesthetic skin itching
10/04/2007WO2007111370A1 Agent for external application to the skin
10/04/2007WO2007111323A1 Ureide derivative and use thereof for medical purposes
10/04/2007WO2007111321A1 Method of analyzing sulfated polysaccharide or sulfated oligosaccharide, pharmaceutical composition and drug containing sulfated polysaccharide or sulfated oligosaccharide, method of producing the pharmaceutical composition and the drug and method of treating, diagnosing, symptom-relieving and preventing disease
10/04/2007WO2007111276A1 Novel ester derivative and use thereof
10/04/2007WO2007111275A1 Method for inhibiting signal transduction, signal transduction inhibitor to be used therein and use thereof
10/04/2007WO2007111238A1 Oral agent for promoting synthesis of tissue collagen
10/04/2007WO2007111227A1 Acylaminopiperidine compound
10/04/2007WO2007111214A1 Trehalose compound and pharmaceutical comprising the compound
10/04/2007WO2007111212A1 Triazolone derivative
10/04/2007WO2007111211A1 Polymer conjugate of taxane
10/04/2007WO2007111203A1 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
1 ... 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 3571 3572 3573 3574 ... 7860